{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:08:40Z","timestamp":1791828520258,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2013-106"],"award-info":[{"award-number":["PICT-2013-106"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012478","name":"Secretaria de Ciencia y Tecnolog\u00eda - Universidad Nacional de C\u00f3rdoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Rett syndrome is a severe and progressive neurological disorder linked to mutations in the MeCP2 gene. It has been suggested that immune alterations may play an active role in the generation and\/or maintenance of RTT phenotypes. However, there is no clear consensus about which pathways are regulated in vivo by MeCP2 in the context of immune activation. In the present work we set to characterize the role of MeCP2 during the progression of Experimental Autoimmune Encephalomyelitis (EAE) using the MeCP2\n                    <jats:sup>308\/y<\/jats:sup>\n                    mouse model (MUT), which represents a condition of \u201cMeCP2 function deficiency\u201d. Our results showed that MeCP2 deficiency increased the susceptibility to develop EAE, along with a defective induction of anti-inflammatory responses and an exacerbated MOG-specific IFN\u03b3 expression in immune sites. In MUT-EAE spinal cord, we found a chronic increase in pro-inflammatory cytokines gene expression (IFN\u03b3, TNF\u03b1 and IL-1\u03b2) and downregulation of genes involved in immune regulation (IL-10, FoxP3 and CX3CR1). Moreover, our results indicate that MeCP2 acts intrinsically upon immune activation, affecting neuroimmune homeostasis by regulating the pro-inflammatory\/anti-inflammatory balance in vivo. These results are relevant to identify the potential consequences of MeCP2 mutations on immune homeostasis and to explore novel therapeutic strategies for MeCP2-related disorders.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-90517-8","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T06:04:00Z","timestamp":1622009040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["MeCP2 deficiency exacerbates the neuroinflammatory setting and autoreactive response during an autoimmune challenge"],"prefix":"10.1038","volume":"11","author":[{"given":"M. I.","family":"Zalosnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Fabio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Bertoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. N.","family":"Casta\u00f1ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Degano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"90517_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-016-0545-5","volume":"11","author":"F Ehrhart","year":"2016","unstructured":"Ehrhart, F. et al. Rett syndrome\u2014Biological pathways leading from MECP2 to disorder phenotypes. Orphanet J. Rare Dis. 11, 1\u201313 (2016).","journal-title":"Orphanet J. Rare Dis."},{"key":"90517_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1086\/382228","volume":"74","author":"JI Young","year":"2004","unstructured":"Young, J. I. & Zoghbi, H. Y. X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of Rett syndrome. Am. J. Hum. Genet. 74, 511\u2013520 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"90517_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mrfmmm.2008.07.007","volume":"647","author":"A Dhasarathy","year":"2008","unstructured":"Dhasarathy, A. & Wade, P. A. The MBD protein family-reading an epigenetic mark? Fundam. Mol. Mech. Mutagen. 647, 39\u201343 (2008).","journal-title":"Fundam. Mol. Mech. Mutagen."},{"key":"90517_CR4","doi-asserted-by":"publisher","first-page":"32181","DOI":"10.1074\/jbc.M305308200","volume":"278","author":"PT Georgel","year":"2003","unstructured":"Georgel, P. T. et al. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem. 278, 32181\u201332188 (2003).","journal-title":"J. Biol. Chem."},{"key":"90517_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","volume":"56","author":"M Chahrour","year":"2007","unstructured":"Chahrour, M. & Zoghbi, H. Y. The story of Rett syndrome: From clinic to neurobiology. Neuron 56, 422\u2013437 (2007).","journal-title":"Neuron"},{"key":"90517_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/30764","volume":"393","author":"X Nan","year":"1998","unstructured":"Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386\u2013389 (1998).","journal-title":"Nature"},{"key":"90517_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.yhbeh.2010.05.014","volume":"59","author":"ES Na","year":"2011","unstructured":"Na, E. S. & Monteggia, L. M. The role of MeCP2 in CNS development and function. Horm. Behav. 59, 364\u2013368 (2011).","journal-title":"Horm. Behav."},{"key":"90517_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185\u2013188 (1999).","journal-title":"Nat. Genet."},{"key":"90517_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neubiorev.2019.05.013","volume":"107","author":"L Cosentino","year":"2019","unstructured":"Cosentino, L., Vigli, D., Franchi, F., Laviola, G. & De Filippis, B. Rett syndrome before regression: A time window of overlooked opportunities for diagnosis and intervention. Neurosci. Biobehav. Rev. 107, 115\u2013135 (2019).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"90517_CR10","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1177\/08830738050200090801","volume":"20","author":"DG Glaze","year":"2014","unstructured":"Glaze, D. G. Neurophysiology of Rett syndrome. J. Child Neurol. 20, 740 (2014).","journal-title":"J. Child Neurol."},{"key":"90517_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0001727","volume":"3","author":"AH Sawalha","year":"2008","unstructured":"Sawalha, A. H. et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS ONE 3, 1\u20137 (2008).","journal-title":"PLoS ONE"},{"key":"90517_CR12","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/art.24360","volume":"60","author":"R Webb","year":"2010","unstructured":"Webb, R. et al. Variants within MECP2, a key transcriptional regulator, are associated with increased susceptibility to lupus and differential gene expression in lupus patients. Arthritis Rheum. 60, 1076\u20131084 (2010).","journal-title":"Arthritis Rheum."},{"key":"90517_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.mce.2014.10.013","volume":"399","author":"R Song","year":"2015","unstructured":"Song, R., Qin, Q., Yan, N., Muhali, F. & Meng, S. Molecular and cellular endocrinology variants in IRAK1-MECP2 region confer susceptibility to autoimmune thyroid diseases. Mol. Cell. Endocrinol. 399, 244\u2013249 (2015).","journal-title":"Mol. Cell. Endocrinol."},{"key":"90517_CR14","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/ard.2009.122903","volume":"69","author":"BL Cobb","year":"2010","unstructured":"Cobb, B. L. et al. Genetic association between methyl-CpG-binding protein 2 (MECP2) and primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 69, 1731\u20131732 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"90517_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/mp.2010.21","volume":"15","author":"NC Derecki","year":"2010","unstructured":"Derecki, N. C., Privman, E. & Kipnis, J. Rett syndrome and other autism spectrum disorders\u2014Brain diseases of immune malfunction? Mol. Psychiatry 15, 355\u2013363 (2010).","journal-title":"Mol. Psychiatry"},{"key":"90517_CR16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cyto.2015.10.002","volume":"77","author":"A Pecorelli","year":"2016","unstructured":"Pecorelli, A. et al. Cytokines profile and peripheral blood mononuclear cells morphology in Rett and autistic patients. Cytokine 77, 180\u2013188 (2016).","journal-title":"Cytokine"},{"key":"90517_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.freeradbiomed.2020.02.023","volume":"152","author":"A Pecorelli","year":"2020","unstructured":"Pecorelli, A., Cervellati, C., Cordone, V., Hayek, J. & Valacchi, G. Compromised immune\/inflammatory responses in Rett syndrome. Free Radic. Biol. Med. 152, 100\u2013106 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"90517_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jneuroim.2015.04.005","volume":"283","author":"CM O\u2019Driscoll","year":"2015","unstructured":"O\u2019Driscoll, C. M., Lima, M. P., Kaufmann, W. E. & Bressler, J. P. Methyl CpG binding protein 2 deficiency enhances expression of inflammatory cytokines by sustaining NF-\u03baB signaling in myeloid derived cells. J. Neuroimmunol. 283, 23\u201329 (2015).","journal-title":"J. Neuroimmunol."},{"key":"90517_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.immuni.2015.03.013","volume":"42","author":"JC Cronk","year":"2015","unstructured":"Cronk, J. C. et al. Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli. Immunity 42, 679\u2013691 (2015).","journal-title":"Immunity"},{"key":"90517_CR20","doi-asserted-by":"publisher","first-page":"421624","DOI":"10.1155\/2015\/421624","volume":"2015","author":"S Leoncini","year":"2015","unstructured":"Leoncini, S. et al. Cytokine dysregulation in MECP2- and CDKL5-related Rett syndrome: Relationships with aberrant redox homeostasis, inflammation, and \u03c9-3 PUFAs. Oxid. Med. Cell. Longev. 2015, 421624 (2015).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"90517_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.biocel.2016.07.015","volume":"81","author":"A Pecorelli","year":"2016","unstructured":"Pecorelli, A., Cervellati, C., Hayek, J. & Valacchi, G. OxInflammation in Rett syndrome. Int. J. Biochem. Cell Biol. 81, 246\u2013253 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"90517_CR22","first-page":"1","volume":"2013","author":"A Pecorelli","year":"2013","unstructured":"Pecorelli, A. et al. Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome. Patients. 2013, 1\u201318 (2013).","journal-title":"Patients."},{"key":"90517_CR23","doi-asserted-by":"publisher","first-page":"101334","DOI":"10.1016\/j.redox.2019.101334","volume":"28","author":"A Pecorelli","year":"2020","unstructured":"Pecorelli, A. et al. Altered inflammasome machinery as a key player in the perpetuation of Rett syndrome oxinflammation. Redox Biol. 28, 101334 (2020).","journal-title":"Redox Biol."},{"key":"90517_CR24","doi-asserted-by":"publisher","first-page":"195935","DOI":"10.1155\/2014\/195935","volume":"2014","author":"C Signorini","year":"2014","unstructured":"Signorini, C. et al. Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome. Oxid. Med. Cell Longev. 2014, 195935 (2014).","journal-title":"Oxid. Med. Cell Longev."},{"key":"90517_CR25","doi-asserted-by":"publisher","first-page":"480980","DOI":"10.1155\/2014\/480980","volume":"2014","author":"A Cortelazzo","year":"2014","unstructured":"Cortelazzo, A. et al. Subclinical inflammatory status in Rett syndrome. Mediat. Inflamm. 2014, 480980 (2014).","journal-title":"Mediat. Inflamm."},{"key":"90517_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2014.04.006","volume":"68","author":"C De Felice","year":"2014","unstructured":"De Felice, C. et al. Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome. Neurobiol. Dis. 68, 66\u201377 (2014).","journal-title":"Neurobiol. Dis."},{"key":"90517_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12974-017-1004-5","volume":"14","author":"E Nance","year":"2017","unstructured":"Nance, E. et al. Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome. J. Neuroinflamm. 14, 252\u2013270 (2017).","journal-title":"J. Neuroinflamm."},{"key":"90517_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","volume":"35","author":"M Shahbazian","year":"2002","unstructured":"Shahbazian, M. et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243\u2013254 (2002).","journal-title":"Neuron"},{"key":"90517_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature12348","volume":"499","author":"DH Ebert","year":"2013","unstructured":"Ebert, D. H. et al. Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature 499, 341\u2013349 (2013).","journal-title":"Nature"},{"key":"90517_CR30","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1007\/s12035-014-9074-1","volume":"53","author":"T Khorshid-Ahmad","year":"2016","unstructured":"Khorshid-Ahmad, T. et al. Transcriptional regulation of brain-derived neurotrophic factor (BDNF) by methyl CpG binding protein 2 (MeCP2): A novel mechanism for re-myelination and\/or myelin repair involved in the treatment of multiple sclerosis (MS). Mol. Neurobiol. 53, 1092\u20131107 (2016).","journal-title":"Mol. Neurobiol."},{"key":"90517_CR31","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1038\/sj.onc.1204340","volume":"20","author":"PA Wade","year":"2001","unstructured":"Wade, P. A. Methyl CpG binding proteins: Coupling chromatin architecture to gene regulation. Oncogene 20, 3166\u20133173 (2001).","journal-title":"Oncogene"},{"key":"90517_CR32","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/nprot.2006.285","volume":"1","author":"IM Stromnes","year":"2006","unstructured":"Stromnes, I. M. & Goverman, J. M. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1, 1810\u20131819 (2006).","journal-title":"Nat. Protoc."},{"key":"90517_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","volume":"162","author":"JM Fletcher","year":"2010","unstructured":"Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N. & Mills, K. H. G. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 162, 1\u201311 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"90517_CR34","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu, C. S., Farooqi, N., O\u2019Brien, K. & Gran, B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 164, 1079\u20131106 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"90517_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/519627","volume":"2013","author":"SFG Zorzella-Pezavento","year":"2013","unstructured":"Zorzella-Pezavento, S. F. G. et al. Persistent inflammation in the CNS during chronic EAE despite local absence of IL-17 production. Mediat. Inflamm. 2013, 1\u201310 (2013).","journal-title":"Mediat. Inflamm."},{"key":"90517_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature10907","volume":"484","author":"NC Derecki","year":"2012","unstructured":"Derecki, N. C. et al. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484, 105\u2013109 (2012).","journal-title":"Nature"},{"key":"90517_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0031814","volume":"7","author":"C Kozlowski","year":"2012","unstructured":"Kozlowski, C. & Weimer, R. M. An automated method to quantify microglia morphology and application to monitor activation state longitudinally in vivo. PLoS ONE 7, 1\u20139 (2012).","journal-title":"PLoS ONE"},{"key":"90517_CR38","doi-asserted-by":"publisher","first-page":"104855","DOI":"10.1016\/j.neuint.2020.104855","volume":"140","author":"K Kikutani","year":"2020","unstructured":"Kikutani, K., Giga, H., Hosokawa, K., Shime, N. & Aizawa, H. Microglial translocator protein and stressor-related disorder. Neurochem. Int. 140, 104855 (2020).","journal-title":"Neurochem. Int."},{"key":"90517_CR39","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/eji.201546194","volume":"46","author":"L Hertwig","year":"2017","unstructured":"Hertwig, L. et al. CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation. Eur. J. Immunol. 46, 1984\u20131996 (2017).","journal-title":"Eur. J. Immunol."},{"key":"90517_CR40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.imbio.2012.08.269","volume":"218","author":"M Rouse","year":"2013","unstructured":"Rouse, M., Nagarkatti, M. & Nagarkatti, P. S. The role of IL-2 in the activation and expansion of regulatory t-cells and the development of experimental autoimmune encephalomyelitis. Immunobiology 218, 674\u2013682 (2013).","journal-title":"Immunobiology"},{"key":"90517_CR41","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.161.7.3299","volume":"161","author":"E Bettelli","year":"1998","unstructured":"Bettelli, E. et al. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161, 3299\u20133306 (1998).","journal-title":"J. Immunol."},{"key":"90517_CR42","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1523\/JNEUROSCI.5966-09.2010","volume":"30","author":"I Maezawa","year":"2010","unstructured":"Maezawa, I. & Jin, L. W. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J. Neurosci. 30, 5346\u20135356 (2010).","journal-title":"J. Neurosci."},{"key":"90517_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.02.015","volume":"15","author":"F Chu","year":"2018","unstructured":"Chu, F. et al. The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 15, 1\u20137 (2018).","journal-title":"J. Neuroimmunol."},{"key":"90517_CR44","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s12035-016-9787-4","volume":"54","author":"\u0141A Poniatowski","year":"2017","unstructured":"Poniatowski, \u0141A. et al. Analysis of the Role of CX3CL1 (Fractalkine) and its receptor CX3CR1 in traumatic brain and spinal cord injury: Insight into recent advances in actions of neurochemokine agents. Mol. Neurobiol. 54, 2167\u20132188 (2017).","journal-title":"Mol. Neurobiol."},{"key":"90517_CR45","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","volume":"91","author":"T Imai","year":"1997","unstructured":"Imai, T. et al. Identification and molecular characterization of fractalkine receptor CX 3 CR1, which mediates both leukocyte migration and adhesion. Cell 91, 521\u2013530 (1997).","journal-title":"Cell"},{"key":"90517_CR46","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1096\/fj.05-5465com","volume":"20","author":"D Huang","year":"2006","unstructured":"Huang, D. et al. The neuronal chemokine CX3CL1\/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20, 896\u2013905 (2006).","journal-title":"FASEB J."},{"key":"90517_CR47","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1084\/jem.20151437","volume":"213","author":"SA L\u00e9vesque","year":"2016","unstructured":"L\u00e9vesque, S. A. et al. Myeloid cell transmigration across the CNS vasculature triggers IL-1 \u03b2-driven neuroidnflammation during autoimmune encephalomyelitis in mice. J. Exp. Med. 213, 929\u2013949 (2016).","journal-title":"J. Exp. Med."},{"key":"90517_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0513-y","volume":"13","author":"A Valentin-torres","year":"2016","unstructured":"Valentin-torres, A. et al. Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis. J. Neuroinflamm. 13, 1\u201314 (2016).","journal-title":"J. Neuroinflamm."},{"key":"90517_CR49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuron.2011.08.022","volume":"72","author":"S Cohen","year":"2011","unstructured":"Cohen, S. et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72\u201385 (2011).","journal-title":"Neuron"},{"key":"90517_CR50","doi-asserted-by":"publisher","first-page":"9467819","DOI":"10.1155\/2017\/9467819","volume":"2017","author":"A Cortelazzo","year":"2017","unstructured":"Cortelazzo, A. et al. Persistent unresolved inflammation in the Mecp2-308 female mutated mouse model of rett syndrome. Mediat. Inflamm. 2017, 9467819 (2017).","journal-title":"Mediat. Inflamm."},{"key":"90517_CR51","doi-asserted-by":"publisher","first-page":"100008","DOI":"10.1016\/j.bbih.2019.100008","volume":"1","author":"BJ Byiers","year":"2020","unstructured":"Byiers, B. J. et al. Evidence of altered salivary cytokine concentrations in Rett syndrome and associations with clinical severity. Brain Behav. Immunity Health 1, 100008 (2020).","journal-title":"Brain Behav. Immunity Health"},{"key":"90517_CR52","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/cmi.2015.10","volume":"2","author":"Z Li","year":"2015","unstructured":"Li, Z., Li, D., Tsun, A. & Li, B. FOXP3 1 regulatory T cells and their functional regulation. Cell. Mol. Immunol. 2, 558\u2013565 (2015).","journal-title":"Cell. Mol. Immunol."},{"key":"90517_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-014-0163-1","volume":"2","author":"M Koutrolos","year":"2014","unstructured":"Koutrolos, M., Berer, K., Kawakami, N., Wekerle, H. & Krishnamoorthy, G. Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS. Acta Neuropathol. Commun. 2, 1\u20137 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"90517_CR54","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.4049\/jimmunol.175.5.3025","volume":"175","author":"MJ Mcgeachy","year":"2005","unstructured":"Mcgeachy, M. J. et al. Natural recovery and protection from autoimmune encephalomyelitis: Contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175, 3025\u20133032 (2005).","journal-title":"J. Immunol."},{"key":"90517_CR55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nm1564","volume":"13","author":"T Korn","year":"2007","unstructured":"Korn, T. et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423\u2013431 (2007).","journal-title":"Nat. Med."},{"key":"90517_CR56","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jns.2017.01.060","volume":"375","author":"A Noori-zadeh","year":"2017","unstructured":"Noori-zadeh, A., Mesbah-namin, S. A. & Saboor-yaraghi, A. A. Epigenetic and gene expression alterations of FOXP3 in the T cells of EAE mouse model of multiple sclerosis. J. Neurol. Sci. 375, 203\u2013208 (2017).","journal-title":"J. Neurol. Sci."},{"key":"90517_CR57","first-page":"2807","volume":"111","author":"C Li","year":"2014","unstructured":"Li, C. et al. MeCP2 enforces Foxp3 expression to promote regulatory T cells\u2019 resilience to inflammation Chaoran. PNAS 111, 2807\u20132816 (2014).","journal-title":"PNAS"},{"key":"90517_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2155-9899.1000400","volume":"7","author":"B Guo","year":"2016","unstructured":"Guo, B. IL-10 Modulates Th17 pathogenicity during autoimmune diseases. J. Clin. Cell Immunol. 7, 1\u201316 (2016).","journal-title":"J. Clin. Cell Immunol."},{"key":"90517_CR59","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.neuroscience.2011.08.076","volume":"199","author":"MJ Bibolini","year":"2011","unstructured":"Bibolini, M. J. et al. Inhibitory role of diazepam on autoimmune inflammation in rats with experimental autoimmune encephalomyelitis. Neuroscience 199, 421\u2013428 (2011).","journal-title":"Neuroscience"},{"key":"90517_CR60","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C T method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90517-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90517-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90517-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T06:00:36Z","timestamp":1675317636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90517-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90517"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90517-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.05.238683","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"2 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10997"}}